Literature DB >> 24500786

Clinically relevant reperfusion in acute ischemic stroke: MTT performs better than Tmax and TTP.

Andria L Ford1, Hongyu An2, Linglong Kong3, Hongtu Zhu4, Katie D Vo5, William J Powers6, Weili Lin2, Jin-Moo Lee1,5.   

Abstract

While several MRI parameters are used to assess tissue perfusion during hyperacute stroke, it is unclear which is optimal for measuring clinically relevant reperfusion. We directly compared mean transit time (MTT) prolongation (MTTp), time-to-peak (TTP), and time-to-maximum (Tmax) to determine which best predicted neurological improvement and tissue salvage following early reperfusion. Acute ischemic stroke patients underwent three MRIs: <4.5 h (tp1), at 6 h (tp2), and at 1 month after onset. Perfusion deficits at tp1 and tp2 were defined by MTTp, TTP, or Tmax beyond four commonly used thresholds. Percent reperfusion (%Reperf) was calculated for each parameter and threshold. Regression analysis was used to fit %Reperf for each parameter and threshold as a predictor of neurological improvement [defined as admission National Institutes of Health Stroke Scale (NIHSS)-1 month NIHSS (∆NIHSS)] after adjusting for baseline clinical variables. Volume of reperfusion, for each parameter and threshold, was correlated with tissue salvage, defined as tp1 perfusion deficit volume-final infarct volume. Fifty patients were scanned at 2.7 and 6.2 h after stroke onset. %Reperf predicted ∆NIHSS for all MTTp thresholds, for Tmax >6 s and >8 s, but for no TTP thresholds. Tissue salvage significantly correlated with reperfusion for all MTTp thresholds and with Tmax >6 s, while there was no correlation with any TTP threshold. Among all parameters, reperfusion defined by MTTp was most strongly associated with ∆NIHSS (MTTp >3 s, P = 0.0002) and tissue salvage (MTTp >3 s and 4 s, P < 0.0001). MTT-defined reperfusion was the best predictor of neurological improvement and tissue salvage in hyperacute ischemic stroke.

Entities:  

Mesh:

Year:  2014        PMID: 24500786      PMCID: PMC4083687          DOI: 10.1007/s12975-014-0325-2

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  29 in total

1.  Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix.

Authors:  Ona Wu; Leif Østergaard; Robert M Weisskoff; Thomas Benner; Bruce R Rosen; A Gregory Sorensen
Journal:  Magn Reson Med       Date:  2003-07       Impact factor: 4.668

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

Authors:  L Ostergaard; A G Sorensen; K K Kwong; R M Weisskoff; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

4.  Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral ischemia.

Authors:  P D Schellinger; J B Fiebach; O Jansen; P A Ringleb; A Mohr; T Steiner; S Heiland; S Schwab; O Pohlers; H Ryssel; B Orakcioglu; K Sartor; W Hacke
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

5.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

6.  Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Authors:  H P Adams; P H Davis; E C Leira; K C Chang; B H Bendixen; W R Clarke; R F Woolson; M D Hansen
Journal:  Neurology       Date:  1999-07-13       Impact factor: 9.910

7.  Magnetic resonance perfusion-weighted imaging of acute cerebral infarction: effect of the calculation methods and underlying vasculopathy.

Authors:  Kei Yamada; Ona Wu; R Gilberto Gonzalez; Dirk Bakker; Leif Østergaard; William A Copen; Robert M Weisskoff; Bruce R Rosen; Katsumi Yagi; Tsunehiko Nishimura; A Gregory Sorensen
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

8.  Predicting outcome after acute and subacute stroke: development and validation of new prognostic models.

Authors:  Carl Counsell; Martin Dennis; Michael McDowall; Charles Warlow
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

9.  Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue.

Authors:  Ludy C Shih; Jeffrey L Saver; Jeffry R Alger; Sidney Starkman; Megan C Leary; Fernando Vinuela; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; J Pablo Villablanca; Paul M Vespa; Chelsea S Kidwell
Journal:  Stroke       Date:  2003-05-08       Impact factor: 7.914

10.  Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era.

Authors:  Julio A Chalela; Dong-Wha Kang; Marie Luby; Mustapha Ezzeddine; Lawrence L Latour; Jason W Todd; Billy Dunn; Steven Warach
Journal:  Ann Neurol       Date:  2004-01       Impact factor: 10.422

View more
  2 in total

1.  Elevated brain oxygen extraction fraction measured by MRI susceptibility relates to perfusion status in acute ischemic stroke.

Authors:  Audrey P Fan; Ahmed A Khalil; Jochen B Fiebach; Greg Zaharchuk; Arno Villringer; Kersten Villringer; Claudine J Gauthier
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

2.  Reperfusion Beyond 6 Hours Reduces Infarct Probability in Moderately Ischemic Brain Tissue.

Authors:  Hongyu An; Andria L Ford; Cihat Eldeniz; Yasheng Chen; Katie D Vo; Hongtu Zhu; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Stroke       Date:  2015-11-19       Impact factor: 7.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.